Literature DB >> 30810025

Treating resistant depression with 2 forms of convulsive therapy: a clinical case study

Anastasios A. Daskalakis, Zafiris J. Daskalakis.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30810025      PMCID： PMC6397037          DOI： 10.1503/jpn.180141

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  12 in total

1.  Magnetic seizure therapy of major depression.

Authors:  S H Lisanby; T E Schlaepfer; H U Fisch; H A Sackeim
Journal:  Arch Gen Psychiatry       Date:  2001-03

Review 2.  Electroconvulsive therapy: a review of history, patient selection, technique, and medication management.

Authors:  Stephen Taylor
Journal:  South Med J       Date:  2007-05       Impact factor: 0.954

3.  Effect of anatomical variability on neural stimulation strength and focality in electroconvulsive therapy (ECT) and magnetic seizure therapy (MST).

Authors:  Zhi-De Deng; Sarah H Lisanby; Angel V Peterchev
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

4.  Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.

Authors:  Charles H Kellner; Rebecca Knapp; Mustafa M Husain; Keith Rasmussen; Shirlene Sampson; Munro Cullum; Shawn M McClintock; Kristen G Tobias; Celena Martino; Martina Mueller; Samuel H Bailine; Max Fink; Georgios Petrides
Journal:  Br J Psychiatry       Date:  2010-03       Impact factor: 9.319

Review 5.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.

Authors:  Roumen V Milev; Peter Giacobbe; Sidney H Kennedy; Daniel M Blumberger; Zafiris J Daskalakis; Jonathan Downar; Mandana Modirrousta; Simon Patry; Fidel Vila-Rodriguez; Raymond W Lam; Glenda M MacQueen; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

6.  Indicators for Remission of Suicidal Ideation Following Magnetic Seizure Therapy in Patients With Treatment-Resistant Depression.

Authors:  Yinming Sun; Faranak Farzan; Benoit H Mulsant; Tarek K Rajji; Paul B Fitzgerald; Mera S Barr; Jonathan Downar; Willy Wong; Daniel M Blumberger; Zafiris J Daskalakis
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

7.  A pilot study of the comparative efficacy of 100 Hz magnetic seizure therapy and electroconvulsive therapy in persistent depression.

Authors:  Paul B Fitzgerald; Kate E Hoy; David Elliot; Susan McQueen; Lenore E Wambeek; Leo Chen; Anne Maree Clinton; Glenn Downey; Zafiris J Daskalakis
Journal:  Depress Anxiety       Date:  2018-01-12       Impact factor: 6.505

8.  Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects.

Authors:  S Kayser; B H Bewernick; A Matusch; R Hurlemann; M Soehle; T E Schlaepfer
Journal:  Psychol Med       Date:  2014-11-25       Impact factor: 7.723

9.  Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.

Authors:  Sarah H Lisanby; Bruce Luber; Thomas E Schlaepfer; Harold A Sackeim
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

10.  Identifying Recipients of Electroconvulsive Therapy: Data From Privately Insured Americans.

Authors:  Samuel T Wilkinson; Edeanya Agbese; Douglas L Leslie; Robert A Rosenheck
Journal:  Psychiatr Serv       Date:  2018-02-01       Impact factor: 3.084
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.